Iress Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Iress heeft een totaal eigen vermogen van A$297.2M en een totale schuld van A$333.3M, wat de schuld-eigenvermogensverhouding op 112.1% brengt. De totale activa en totale passiva bedragen respectievelijk A$788.5M en A$491.3M. De EBIT Iress is A$46.5M waardoor de rentedekking 2.4 is. Het heeft contanten en kortetermijnbeleggingen van A$41.9M.

Belangrijke informatie

112.1%

Verhouding schuld/eigen vermogen

AU$333.28m

Schuld

Rente dekkingsratio	2.4x
Contant	AU$41.89m
Aandelen	AU$297.21m
Totaal verplichtingen	AU$491.29m
Totaal activa	AU$788.50m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( A$234.4M ) IRE } overtreffen de korte termijn passiva ( A$118.6M ).

Langlopende schulden: De kortetermijnactiva van IRE ( A$234.4M ) dekken de langetermijnschulden ( A$372.7M ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 98% ) IRE wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van IRE is de afgelopen 5 jaar gestegen van 54.5% naar 112.1%.

Schuldendekking: De schuld van IRE wordt niet goed gedekt door de operationele kasstroom ( 19.1% ).

Rentedekking: De rentebetalingen van IRE op haar schulden worden niet goed gedekt door EBIT ( 2.4 x dekking).

Iress Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Iress Limited Plan to Reinstate a Final Dividend for Fiscal Year 2024, Payable in March 2025

First half 2024 earnings released: EPS: AU$0.095 (vs AU$0.77 loss in 1H 2023)

Waiting Game for Blackstone with Low-Ball Offer for Iress Up in Air

Iress Limited to Report First Half, 2024 Results on Aug 19, 2024

Praemium Limited (ASX:PPS) agreed to acquire OneVue Holdings Limited from Iress Limited (ASX:IRE) for AUD 21 million.

Full year 2023 earnings released: AU$0.76 loss per share (vs AU$0.29 profit in FY 2022)

Iress Limited, Annual General Meeting, May 02, 2024

Iress Limited to Report Second Half, 2023 Results on Feb 21, 2024

Iress Announces Executive Changes

Independent Non-Executive Chairman recently bought AU$200k worth of stock

SS&C Technologies Holdings, Inc. (NasdaqGS:SSNC) entered into definitive agreement to acquire Managed funds administration business of Iress for AUD 52 million.

First half 2023 earnings released: AU$0.77 loss per share (vs AU$0.16 profit in 1H 2022)

SS&C Technologies Holdings, Inc. (NasdaqGS:SSNC) entered into definitive agreement to acquire Managed funds administration business of Iress.

Iress Limited Announces Resignation of Peter Ferguson as Company Secretary Effective 10 August 2023

Now 20% undervalued

Iress Limited Appoints Georgina Gillingham as an Additional Company Secretary

Iress Limited Appoints Cameron Williamson as Group Chief Financial Officer, Effective from 24 July 2023

Iress Limited to Report Q2, 2023 Results on Aug 21, 2023

Independent Non-Executive Chairman recently bought AU$73k worth of stock

Full year 2022 earnings released: EPS: AU$0.29 (vs AU$0.39 in FY 2021)

Iress Limited, Annual General Meeting, May 04, 2023

Iress Limited to Report Fiscal Year 2022 Results on Feb 20, 2023

An unknown buyer acquired an unknown stake in Iress Limited (ASX:IRE) from Mirrabooka Investments Limited (ASX:MIR).

High number of new directors

High number of new directors

Iress Limited Appoints Anthony James Glenning as Non-Executive Director

MD, CEO & Director recently bought AU$203k worth of stock

Investor sentiment deteriorated over the past week

Non-Executive Director recently bought AU$300k worth of stock

Iress Limited Announces Joining of Anthony Glenning as Independent Non-Executive Director, Effective October 11, 2022

Upcoming dividend of AU$0.16 per share

First half 2022 earnings released: EPS: AU$0.16 (vs AU$0.21 in 1H 2021)

Iress Limited Announces Ordinary Franked Dividend for the Six Months Ended June 30, 2022, Payable on September 23, 2022

Iress Limited Appoints Marcus Colin Price as Non-Executive Director

Iress Limited Provides Earnings Guidance for the First Half of Year 2022 and Reaffirms Earnings Guidance for the Full Year 2022

Now 21% undervalued

Investor sentiment improved over the past week

Independent Non-Executive Director recently bought AU$130k worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Iress Limited Announces Ordinary Franked Dividend for the Six Months Ended December 31, 2021, Payable on March 18, 2022

Iress Limited, Annual General Meeting, May 05, 2022

Iress Limited to Report First Half, 2022 Results on Aug 18, 2022

Iress Limited to Report Fiscal Year 2021 Results on Feb 17, 2022

EQT Fund Management S.à r.l. cancelled the acquisition of Iress Limited (ASX:IRE).

Upcoming dividend of AU$0.16 per share

First half 2021 earnings released: EPS AU$0.21 (vs AU$0.15 in 1H 2020)

Investor sentiment improved over the past week

Independent Non-Executive Director has left the company

Independent Non-Executive Director has left the company

Independent Chairman of the Board Anthony D'Aloisio has left the company

Iress Limited Increases Earnings Guidance for the Fiscal Year 2021

Non-Executive Director recently bought AU$100k worth of stock

New 90-day low: AU$9.77

Full year 2020 earnings released: EPS AU$0.32 (vs AU$0.38 in FY 2019)

Revenue misses expectations

IRESS Limited Announces Board Changes

New 90-day high: AU$10.71

IRESS Limited (ASX:IRE) completed the acquisition of OneVue Holdings Limited (ASX:OVH) from Thorney Investment Group Australia Pty. Ltd., Abtourk Group and others.

IRESS Limited to Report First Half, 2021 Results on Aug 19, 2021

New 90-day low: AU$9.42

New 90-day low: AU$9.45

IRESS Limited (ASX:IRE) entered into an implementation agreement to acquire OneVue Holdings Limited (ASX:OVH) from Thorney Investment Group Australia Pty. Ltd., Abtourk Group and others for approximately AUD 120 million.

Independent Non-Executive Director recently bought AU$52k worth of stock

New 90-day low - AU$9.98

First half earnings released

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven